Fulladosa Oliveras X - Search Results

Year	Number of Results
2009	1
2014	1
2015	1
2016	2
2018	1
2019	1
2020	3
2021	2
2022	1
2023	1
2024	2

1

Avacopan for the Treatment of ANCA-Associated Vasculitis.

Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Jayne DRW, et al. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. N Engl J Med. 2021. PMID: 33596356 Clinical Trial.

2

Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.

Geetha D, Dua A, Yue H, Springer J, Salvarani C, Jayne D, Merkel P; ADVOCATE Study Group. Geetha D, et al. Ann Rheum Dis. 2024 Jan 11;83(2):223-232. doi: 10.1136/ard-2023-224816. Ann Rheum Dis. 2024. PMID: 37979959 Free PMC article. Clinical Trial.

3

Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.

Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Er L, Reich HN, Barratt J, Cattran DC; International IgA Nephropathy Network. Barbour SJ, et al. Kidney Int. 2022 Jul;102(1):160-172. doi: 10.1016/j.kint.2022.02.042. Epub 2022 Apr 29. Kidney Int. 2022. PMID: 35490842 Free article.

4

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

Strand V, Jayne DRW, Horomanski A, Yue H, Bekker P, Merkel PA; ADVOCATE Study Group. Strand V, et al. Lancet Rheumatol. 2023 Aug;5(8):e451-e460. doi: 10.1016/S2665-9913(23)00092-9. Epub 2023 Jul 24. Lancet Rheumatol. 2023. PMID: 38251577 Clinical Trial.

5

Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

Bellur SS, Troyanov S, Vorobyeva O, Coppo R, Roberts ISD; Validation in IgA Nephropathy study group. Bellur SS, et al. Kidney Int. 2024 Mar 28:S0085-2538(24)00235-7. doi: 10.1016/j.kint.2024.03.011. Online ahead of print. Kidney Int. 2024. PMID: 38554992

6

T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach.

Martinez Valenzuela L, Bordignon Draibe J, Fulladosa Oliveras X, Bestard Matamoros O, Cruzado Garrit JM, Torras Ambrós J. Martinez Valenzuela L, et al. Among authors: fulladosa oliveras x. Clin Kidney J. 2019 Apr 19;12(4):503-511. doi: 10.1093/ckj/sfz029. eCollection 2019 Aug. Clin Kidney J. 2019. PMID: 31384441 Free PMC article.

7

[The influenza virus A/H1N1 in the nephrological patient. The pandemic that has put us on alert].

Martínez Castelao A, Carratalà J, Fernández Fresnedo G, Fulladosa Oliveras X, Górriz JL, Portolés JM, Quereda C, Hernández RS. Martínez Castelao A, et al. Among authors: fulladosa oliveras x. Nefrologia. 2009;29(6):503-5. doi: 10.3265/Nefrologia.2009.29.6.5861.en.full. Nefrologia. 2009. PMID: 19935993 Free article. Spanish. No abstract available.

8

Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.

Barbour SJ, Canney M, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Induruwage D, Er L, Reich HN, Feehally J, Barratt J, Cattran DC; International IgA Nephropathy Network. Barbour SJ, et al. Kidney Int. 2020 Oct;98(4):1009-1019. doi: 10.1016/j.kint.2020.04.042. Epub 2020 May 25. Kidney Int. 2020. PMID: 32464215

9

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia. Barbour SJ, et al. Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322. Kidney Int. 2016. PMID: 26759049 Free article.

10

Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis.

Martinez Valenzuela L, Draibe J, Quero Ramos M, Fulladosa Oliveras X, Melilli E, Cruzado Garrit JM, Torras Ambrós J. Martinez Valenzuela L, et al. Among authors: fulladosa oliveras x. PLoS One. 2018 Oct 22;13(10):e0205982. doi: 10.1371/journal.pone.0205982. eCollection 2018. PLoS One. 2018. PMID: 30347000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year